<!DOCTYPE html>

<html>
  <head>
    <title></title>
    <link rel="stylesheet" type="text/css" href="../css/reset.css">
    <link rel="stylesheet" type="text/css" href="../css/grid.css">
    <link rel="stylesheet" type="text/css" href="../css/style_t.css">
 	
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <meta name="description" content="Blog post">

     <meta property="og:description" content="Aurametrix is developing a portable, easy-to-use platform to alleviate metabolic disorders by measuring the body’s early responses to specific foods, activities and therapies" />
    <meta name="author" content="">
<!--
<meta name="google-site-verification" content="viSFUMm8kGibfn0m9jqaKylLbekJwem1sABKllXTD00">
-->

    <link rel="shortcut icon" href="../favicon.ico" type="image/x-icon">


	 </head>
  <body>
  
 
    <div id="wrapper" class="grid clearfix">
      <div id="main" class="grid-1">
      <!--  <div id="logo"><h1>Blog</h1></div> -->
     <h1>Random posts</h1>

	 <div dir="ltr" style="text-align: left;" trbidi="on">

     <li><a href="./skingut.html">Gut and Skin</a>: 11/4/2020
     <li><a href="./mmedicine.html">Microbiome medicine</a>: 9/30/2020
     <li><a href="./cdogs.html">Sniffing COVID</a>: 6/30/2020
     <li><a href="./vaccines.html">Vaccines</a>: 5/21/2020
     <li><a href="./restart.html">Restart</a>: 4/26/2020
     <li><a href="./covid19gp.html">SARS-CoV-2</a>: 4/13/2020
     <li><a href="./workless.html">Work Less</a>: 3/7/2020
     <li><a href="./feelbetter.html">Feel Better</a>: 2/19/2020
	 <li><a href=".//mdx.html">Microbial Dx</a>: 2/10/2020
     <li><a href="./pond.html">Saving the Pond</a>: 8/28/2019
	 <li><a href="https://aurametrix.weebly.com/blog/bringing-health-and-happiness">Animal Happiness</a>: 11/10/2017	
	 <li><a href="https://environment.aurametrix.com/2015/05/cities-of-future.html">Cities of The Future</a>: 5/17/2015	

     <br>
	 <h1><a href="../blog.html">Blog Archives</a></h1>

  </div> </div>
	  
      <div class="grid grid-3">
  

		
		  
		          <div id="recently-updated" class="grid-2 alpha header">
   <h1>The Many Genes of TMAU</h1>    
   <h6>&nbsp;&nbsp;&nbsp Friday, October 23, 2020</h6>
        </div>
		  
<p><span style="font-family: times;"><span style="color: #1c1d1e;">Twenty years ago Trimethylaminuria (TMAU), also known as fish odor syndrome, was linked to mutations in the gene coding an enzyme named flavin-containing monooxygenase 3 (FMO3). The flavin-containing monooxygenase (FMO) protein family specializes in the oxidation of xeno-substrates - chemicals foreign to the body. The chemicals processed by&nbsp;</span><span style="color: #1c1d1e;">monooxygenases,&nbsp;</span><span style="color: #1c1d1e;">particularly tertiary </span></span></p><div class="separator" style="clear: both; text-align: center;"><span style="color: #1c1d1e; font-family: times;"><a href="https://upload.wikimedia.org/wikipedia/commons/4/47/SimpleGenotypePhenotypeMap.jpg" style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"><img border="0" data-original-height="800" data-original-width="800" height="200" src="https://upload.wikimedia.org/wikipedia/commons/4/47/SimpleGenotypePhenotypeMap.jpg" width="200" /></a></span></div><span style="font-family: times;"><span style="color: #1c1d1e;">acyclic and cyclic amines,&nbsp;</span><span style="color: #1c1d1e;">are introduced into the body from the diet (e.g. from fish, eggs), medicines (such as mental health drugs imipramine, clozapine, and amphetamine, cancer drugs/hormones such as tamoxifen and NSAID&nbsp;</span><span style="color: #1c1d1e;">Sulindac sulfide</span><span style="color: #1c1d1e;">), stimulants (nicotine) and other environmental exposures. FMO enzymes&nbsp;</span><span style="color: #1c1d1e;">convert these compounds to stable N-oxides,</span><span style="color: #1c1d1e;">&nbsp;</span><span style="color: #1c1d1e;">&nbsp;facilitating the excretion from the body. The FMO3 enzyme, produced in the liver, is responsible for breaking down nitrogen-containing compounds mostly derived from the diet. In a healthy individual, 95% or more of fish-and-garbage-smelling by-product trimethylamine (TMA) is converted by this enzyme to non-odorous trimethylamine N-oxide (TMA N-oxide).</span></span><p></p><p><span face="Open Sans, icomoon, sans-serif" style="color: #1c1d1e;"><span style="background-color: white; font-family: times;">The recessive disorder trimethylaminuria (TMAU) was originally thought to be caused exclusively by defects in the FMO3 gene. 3 major faults were initially discovered in 1997, but the number grew to 40 in 2011. Genetic study published 3 years ago suggested there could be multiple impairments of genes and their protein products along the FMO3 metabolic pathway. Genes possibly implicated in TMAU included those with oxidoreductase function ( such as PYROXD2, Pyridine Nucleotide-Disulphide Oxidoreductase) and a DMGDH (dimethylglycine dehydrogenase).</span></span></p><p><span face="Open Sans, icomoon, sans-serif" style="color: #1c1d1e;"><span style="background-color: white; font-family: times;">A pilot study published this month identified two new genes - heat shock proteins and chaperones. As the authors say "Although, to
date, there is little evidence of interaction between HSPA8 and FMO3,
two possible mechanisms for further investigation can be considered. The
first regards the role of HSPA8 in FMO3 folding, assembly, and
stabilization. The second one is related to HSPA8 as mediator of FMO3
degradation."</span></span></p><br><p>
<span style="font-family: times;">This discovery makes is hard to avoid ending this post with a cliché "more research is needed".</span></p><p><br /></p><p><span style="background: white; color: #1c1d1e; font-size: 13.5pt;">

<br>
REFERENCES</span><span style="font-size: 13.5pt;"><o:p></o:p></span></p><p><span style="font-size: 13.5pt;">&nbsp;</span><span style="font-size: 13.5pt; text-indent: -0.25in;">1.<span style="font-size: 7pt; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: normal;">&nbsp;&nbsp;&nbsp;

</span></span><span style="background: white; font-family: Georgia, serif; font-size: 12.5pt; text-indent: -0.25in;">Humbert, J. R., Hammond, K. B., Hathaway, W. E.,
Marcoux, J., O'Brien, D.&nbsp;<b>Trimethylaminuria: the fish-odour syndrome.
(Letter)</b>&nbsp;Lancet 296: 770-771, 1970.</span></p><p><span style="font-size: 13.5pt; text-indent: -0.25in;">2.<span style="font-size: 7pt; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: normal;">&nbsp;&nbsp;&nbsp;
</span></span><!--[endif]--><span style="background: white; font-family: Georgia, serif; font-size: 12.5pt; text-indent: -0.25in;">Akerman, B. R., Chow, L., Forrest, S., Youil, R.,
Cashman, J., Treacy, E. P.&nbsp;<b>Mutations in the flavin-containing
monoxygenase (sic) form 3 (FMO3) gene cause trimethylaminuria, fish odour
syndrome. (Abstract)</b>&nbsp;Am. J. Hum. Genet. 61 (suppl.): A53 only, 1997.</span></p><p><span style="font-size: 13.5pt; text-indent: -0.25in;">3.<span style="font-size: 7pt; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: normal;">&nbsp;&nbsp;&nbsp;
</span></span><!--[endif]--><span style="background: white; font-family: Georgia, serif; font-size: 12.5pt; text-indent: -0.25in;">Dolphin, C. T., Janmohamed, A., Smith, R. L.,
Shephard, E. A., Phillips, I. R.&nbsp;<b>Missense mutation in flavin-containing
mono-oxygenase 3 gene, FMO3, underlies fish-odour syndrome.</b>&nbsp;Nature
Genet. 17: 491-494, 1997.&nbsp;</span></p><p><span style="font-size: 13.5pt; text-indent: -0.25in;">4.<span style="font-size: 7pt; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: normal;">&nbsp;&nbsp;&nbsp;
</span></span><!--[endif]--><span style="background: white; font-family: Georgia, serif; font-size: 12.5pt; text-indent: -0.25in;">Phillips IR, Shephard EA.&nbsp;<b>Flavin-containing
monooxygenases: mutations, disease and drug response.</b>&nbsp;Trends in
pharmacological sciences. 2008 Jun 1;29(6):294-301.</span></p><p><span style="font-size: 13.5pt; text-indent: -0.25in;">5.<span style="font-size: 7pt; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: normal;">&nbsp;&nbsp;&nbsp;
</span></span><!--[endif]--><span style="background: white; font-family: Georgia, serif; font-size: 12.5pt; text-indent: -0.25in;">Hernandez, D., Addou, S., Lee, D., Orengo, C.,
Shephard, E. A., Phillips, I. R.&nbsp;<b>Trimethylaminuria and a human FMO3
mutation database.</b>&nbsp;Hum. Mutat. 22: 209-213, 2003.</span></p><p><span style="font-size: 13.5pt; text-indent: -0.25in;">6.<span style="font-size: 7pt; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: normal;">&nbsp;&nbsp;&nbsp;
</span></span><!--[endif]--><span style="background: white; font-family: Georgia, serif; font-size: 13.5pt; text-indent: -0.25in;">Guo Y, Hwang LD, Li J, Eades J, Yu CW, Mansfield
C, Burdick-Will A, Chang X, Chen Y, Duke FF, Zhang J.&nbsp;<b>Genetic analysis
of impaired trimethylamine metabolism using whole exome sequencing.&nbsp;</b>BMC
medical genetics. 2017 Dec 1;18(1):11.</span></p><p><span style="font-size: 13.5pt; text-indent: -0.25in;">7.<span style="font-size: 7pt; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: normal;">&nbsp;&nbsp;&nbsp;
</span></span><!--[endif]--><span style="background: white; font-family: Georgia, serif; font-size: 13.5pt; text-indent: -0.25in;">Scimone C, Alibrandi S, Donato L, Esposito T,
Sidoti A, D’Angelo R.&nbsp;<b>Variants of the molecular chaperone hspa8 and
hspa1a genes in trimethylaminuria: a pilot study.</b>&nbsp;Euromediterranean
biomedical journal 2020,15 (38) 157–160 (formerly: capsula eburnea)&nbsp;</span></p><p>




           <p>&nbsp;</p>

		   		          <!-- <div id="post" class="grid-4 omega header">  -->

<br />
<br />
<br />
<br />

		  </p>

        </div>


      </div>

    </div>
    
  </body>
</html>